Tacedinaline - Pfizer
Alternative Names: Ac-Din; Acetyldinaline; CI 994; GOE 5549; PD 123654; PD 130636Latest Information Update: 27 Sep 2024
At a glance
- Originator Goedecke; Pfizer
- Developer Pfizer
- Class Aniline compounds; Antidementias; Antineoplastics
- Mechanism of Action Beta catenin modulators; Histone deacetylase inhibitors; Wnt signalling pathway modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Alzheimer's disease
- Discontinued Breast cancer; Colorectal cancer; Lung cancer; Pancreatic cancer